Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 265

Similar articles for PubMed (Select 16298482)

1.

LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.

Infante J, Rodríguez E, Combarros O, Mateo I, Fontalba A, Pascual J, Oterino A, Polo JM, Leno C, Berciano J.

Neurosci Lett. 2006 Mar 13;395(3):224-6. Epub 2005 Nov 18.

PMID:
16298482
2.

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E.

Arch Neurol. 2006 Mar;63(3):377-82.

PMID:
16533964
3.

LRRK2 mutations are a common cause of Parkinson's disease in Spain.

Mata IF, Ross OA, Kachergus J, Huerta C, Ribacoba R, Moris G, Blazquez M, Guisasola LM, Salvador C, Martinez C, Farrer M, Alvarez V.

Eur J Neurol. 2006 Apr;13(4):391-4.

PMID:
16643318
4.

Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.

Gao L, Gómez-Garre P, Díaz-Corrales FJ, Carrillo F, Carballo M, Palomino A, Díaz-Martín J, Mejías R, Vime PJ, López-Barneo J, Mir P.

Eur J Neurol. 2009 Aug;16(8):957-60. doi: 10.1111/j.1468-1331.2009.02620.x. Epub 2009 Mar 31.

PMID:
19473361
5.

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.

Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.

Eur J Neurol. 2007 Apr;14(4):413-7.

PMID:
17388990
6.

LRRK2 R1441G in Spanish patients with Parkinson's disease.

Mata IF, Taylor JP, Kachergus J, Hulihan M, Huerta C, Lahoz C, Blazquez M, Guisasola LM, Salvador C, Ribacoba R, Martinez C, Farrer M, Alvarez V.

Neurosci Lett. 2005 Jul 15;382(3):309-11. Epub 2005 Apr 13.

PMID:
15925109
7.

A study of LRRK2 mutations and Parkinson's disease in Brazil.

Pimentel MM, Moura KC, Abdalla CB, Pereira JS, de Rosso AL, Nicaretta DH, Campos M Jr, de Almeida RM, dos Santos JM, Bastos IC, Mendes MF, Maultasch H, Costa FH, Werneck AL, Santos-Rebouças CB.

Neurosci Lett. 2008 Mar 5;433(1):17-21. doi: 10.1016/j.neulet.2007.12.033. Epub 2007 Dec 23.

PMID:
18201824
8.

[Clinical features of LRRK2-associated Parkinson's disease].

Pchelina SN, Ivanova ON, Emel'ianov AK, Iakimovskiĭ AF.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(12):56-62. Russian.

PMID:
22433811
9.

High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain).

Sierra M, González-Aramburu I, Sánchez-Juan P, Sánchez-Quintana C, Polo JM, Berciano J, Combarros O, Infante J.

Mov Disord. 2011 Nov;26(13):2343-6. doi: 10.1002/mds.23965. Epub 2011 Sep 27.

PMID:
21954089
10.

[Genetic screening for the LRRK2, G2019S and R1441 codon mutations in Parkinson's disease patients from Extremadura, Spain].

Morán JM, Castellanos-Pinedo F, Casado-Naranjo I, Durán-Herrera C, Ramírez-Moreno JM, Gómez M, Zurdo-Hernández JM, Fuentes E, Ortiz-Ortiz MA, Moreno AD, González-Polo RA, Niso-Santano M, Bravo-Sanpedro JM, Pérez-Tur J, Ruiz-Mesa LM, Fuentes JM.

Rev Neurol. 2010 May 16;50(10):591-4. Spanish.

11.

Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.

Floris G, Cannas A, Solla P, Murru MR, Tranquilli S, Corongiu D, Rolesu M, Cuccu S, Sardu C, Marrosu F, Marrosu MG.

Parkinsonism Relat Disord. 2009 May;15(4):277-80. doi: 10.1016/j.parkreldis.2008.06.009. Epub 2008 Sep 20.

PMID:
18805725
12.

Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.

Perez-Pastene C, Cobb SA, Díaz-Grez F, Hulihan MM, Miranda M, Venegas P, Godoy OT, Kachergus JM, Ross OA, Layson L, Farrer MJ, Segura-Aguilar J.

Neurosci Lett. 2007 Jul 18;422(3):193-7. Epub 2007 Jun 17.

13.

LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.

Gorostidi A, Ruiz-Martínez J, Lopez de Munain A, Alzualde A, Martí Massó JF.

Neurogenetics. 2009 Apr;10(2):157-9. doi: 10.1007/s10048-008-0162-0. Epub 2008 Nov 20.

PMID:
19020907
14.

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.

Ferreira JJ, Guedes LC, Rosa MM, Coelho M, van Doeselaar M, Schweiger D, Di Fonzo A, Oostra BA, Sampaio C, Bonifati V.

Mov Disord. 2007 Jun 15;22(8):1194-201.

PMID:
17469194
15.

Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.

Huang Y, Halliday GM, Vandebona H, Mellick GD, Mastaglia F, Stevens J, Kwok J, Garlepp M, Silburn PA, Horne MK, Kotschet K, Venn A, Rowe DB, Rubio JP, Sue CM.

Mov Disord. 2007 May 15;22(7):982-9.

PMID:
17427941
16.

Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.

Yahalom G, Kaplan N, Vituri A, Cohen OS, Inzelberg R, Kozlova E, Korczyn AD, Rosset S, Friedman E, Hassin-Baer S.

Parkinsonism Relat Disord. 2012 Nov;18(9):1039-41. doi: 10.1016/j.parkreldis.2012.05.014. Epub 2012 Jun 13.

PMID:
22703868
17.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2006 Nov 28;67(10):1786-91. Epub 2006 Oct 18.

PMID:
17050822
18.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N.

Neurology. 2007 Oct 16;69(16):1595-602.

PMID:
17938369
19.

G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.

Pchelina SN, Yakimovskii AF, Ivanova ON, Emelianov AK, Zakharchuk AH, Schwarzman AL.

Mov Disord. 2006 Dec;21(12):2234-6.

PMID:
17044089
20.

Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.

Yescas P, López M, Monroy N, Boll MC, Rodríguez-Violante M, Rodríguez U, Ochoa A, Alonso ME.

Neurosci Lett. 2010 Nov 19;485(2):79-82. doi: 10.1016/j.neulet.2010.08.029. Epub 2010 Aug 18.

PMID:
20727385
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk